M Uehara, D Yasuhara, T Nakahara… - … & diabetes: official …, 2011 - ncbi.nlm.nih.gov Restricting-type of anorexia nervosa (AN-R) is a serious disorder affecting adolescents and young adults, and decreases quality of life over long period. Successful weight restoration is an important prognostic factor for disease outcome; however, the underlying mechanism of refeeding- ...
MT Ha, HW Marsh… - … , motivation and identity: where to from …, 2011 - deakin.edu.au Ha, My Trinh, Marsh, Herbert W. and Halse, Christine 2004, What you see is not always what you get : the self-concepts of adolescent girls with anorexia nervosa., in SELF 2003 : Self-concept, motivation and identity : where to from here? : Proceedings of the 3rd ... Cached
SE Racine, TL Root, KL Klump… - Eating Disorders in …, 2011 - books.google.com CHAPtEr 3 Environmental and Genetic Risk Factors for Eating Disorders A Developmental Perspective Sarah E. Racine Tammy L. Root Kelly L. Klump Cynthia M. Bulik o ver the past two decades it has become increasingly clear that early conceptualiza- tions of eating disorders as ...
J Barbier, L Gabriëls, K Laere… - Neurosurgery, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > ... Related articles - All 4 versions
J Hagman, J Gralla, E Sigel, S Ellert… - Journal of the American …, 2011 - Elsevier The mean dose for the risperidone group was 2.5 mg and for the placebo group was 3 mg for a mean duration of 9 weeks. Subjects taking risperidone had a significant decrease on the Eating Disorder Inventory 2 Drive for Thinness subscale over the first 7 weeks (effect size, 0.88; p ... Cited by 1